Published in Am J Trop Med Hyg on December 01, 2006
Toward a Mechanistic Understanding of Environmentally Forced Zoonotic Disease Emergence: Sin Nombre Hantavirus. Bioscience (2015) 0.78
Seasonal Fluctuations of Astrovirus, But Not Coronavirus Shedding in Bats Inhabiting Human-Modified Tropical Forests. Ecohealth (2017) 0.76
Estimating duration of infection with avidity assays: potential limitations and recommendations for improvement. Ecohealth (2012) 0.76
Development of an ELISA to detect Sin Nombre virus-specific IgM from deer mice (Peromyscus maniculatus). J Virol Methods (2008) 0.76
Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype. Virology (2005) 3.14
Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog (2010) 3.08
West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ (2003) 3.03
Comparison of dengue virus type 2-specific small RNAs from RNA interference-competent and -incompetent mosquito cells. PLoS Negl Trop Dis (2010) 2.18
Persistent Sin Nombre virus infection in the deer mouse (Peromyscus maniculatus) model: sites of replication and strand-specific expression. J Virol (2003) 2.09
Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis (2004) 2.00
Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in chile. J Infect Dis (2007) 1.97
Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein. J Virol (2010) 1.81
Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models. J Virol (2010) 1.72
Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype? PLoS Pathog (2010) 1.70
Drug Repurposing from an Academic Perspective. Drug Discov Today Ther Strateg (2011) 1.68
Shedding and intracage transmission of Sin Nombre hantavirus in the deer mouse (Peromyscus maniculatus) model. J Virol (2002) 1.62
Identification of rodent homologs of hepatitis C virus and pegiviruses. MBio (2013) 1.61
An outbreak of West Nile virus-associated disease in domestic geese (Anser anser domesticus) upon initial introduction to a geographic region, with evidence of bird to bird transmission. Can Vet J (2004) 1.55
Detection of polyoma and corona viruses in bats of Canada. J Gen Virol (2009) 1.49
West Nile virus surveillance and diagnostics: A Canadian perspective. Can J Infect Dis (2003) 1.44
Susceptibility of pigs and chickens to SARS coronavirus. Emerg Infect Dis (2004) 1.35
Comparison of assays for the detection of West Nile virus antibodies in chicken serum. Can J Vet Res (2003) 1.33
Genetic interaction between distinct Dobrava hantavirus subtypes in Apodemus agrarius and A. flavicollis in nature. J Virol (2003) 1.32
Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol (2010) 1.31
Regulatory T cell-like responses in deer mice persistently infected with Sin Nombre virus. Proc Natl Acad Sci U S A (2007) 1.28
Emerging viruses: the case 'hantavirus'. Intervirology (2002) 1.27
Ecology, genetic diversity, and phylogeographic structure of andes virus in humans and rodents in Chile. J Virol (2008) 1.24
Characterization of a Cdc42 protein inhibitor and its use as a molecular probe. J Biol Chem (2013) 1.24
Induction of innate immune response genes by Sin Nombre hantavirus does not require viral replication. J Virol (2005) 1.20
Diagnosis and treatment of new world hantavirus infections. Curr Opin Infect Dis (2006) 1.18
Mutations in the NS1 C-terminal tail do not enhance replication or virulence of the 2009 pandemic H1N1 influenza A virus. J Gen Virol (2010) 1.16
West Nile virus outbreak in North American owls, Ontario, 2002. Emerg Infect Dis (2004) 1.16
Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome. J Infect Dis (2006) 1.14
A seroprevalence study of west nile virus infection in solid organ transplant recipients. Am J Transplant (2004) 1.09
Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus. J Virol (2009) 1.08
Highly differentiated, resting gn-specific memory CD8+ T cells persist years after infection by andes hantavirus. PLoS Pathog (2010) 1.08
Design of oligonucleotide arrays to detect point mutations: molecular typing of antibiotic resistant strains of Neisseria gonorrhoeae and hantavirus infected deer mice. Mol Cell Probes (2003) 1.06
Hantavirus prevalence in the IX Region of Chile. Emerg Infect Dis (2003) 1.05
Early innate immune responses to Sin Nombre hantavirus occur independently of IFN regulatory factor 3, characterized pattern recognition receptors, and viral entry. J Immunol (2007) 1.04
High seroprevalence of hantavirus infection on the Azuero peninsula of Panama. Am J Trop Med Hyg (2004) 1.04
Ribavirin, human convalescent plasma and anti-beta3 integrin antibody inhibit infection by Sin Nombre virus in the deer mouse model. J Gen Virol (2007) 1.02
Distribution and phylogenetic comparisons of a novel mosquito flavivirus sequence present in Culex tarsalis Mosquitoes from western Canada with viruses isolated in California and Colorado. Am J Trop Med Hyg (2011) 1.01
Enhanced detection of Rift Valley fever virus using molecular assays on whole blood samples. J Clin Virol (2012) 0.99
Hantavirus infection and habitat associations among rodent populations in agroecosystems of Panama: implications for human disease risk. Am J Trop Med Hyg (2009) 0.99
Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus. J Virol Methods (2004) 0.99
Clinical utility of commercial enzyme immunoassays during the inaugural season of West Nile virus activity, Alberta, Canada. J Clin Microbiol (2005) 0.98
New World hantaviruses activate IFNlambda production in type I IFN-deficient vero E6 cells. PLoS One (2010) 0.98
Kinetics of immune responses in deer mice experimentally infected with Sin Nombre virus. J Virol (2012) 0.98
Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor. J Virol (2005) 0.96
Cluster of cases of hantavirus pulmonary syndrome in Alberta, Canada. Am J Trop Med Hyg (2007) 0.95
Neutralizing antibodies and Sin Nombre virus RNA after recovery from hantavirus cardiopulmonary syndrome. Emerg Infect Dis (2004) 0.94
Experimental Andes virus infection in deer mice: characteristics of infection and clearance in a heterologous rodent host. PLoS One (2013) 0.94
Evaluation of commercial assays for detecting West Nile virus antigen. J Am Mosq Control Assoc (2006) 0.94
West Nile Virus infection in humans and horses, Cuba. Emerg Infect Dis (2006) 0.94
Serological assays for the detection of human andes hantavirus infections based on its yeast-expressed nucleocapsid protein. Intervirology (2006) 0.93
Does high biodiversity reduce the risk of Lyme disease invasion? Parasit Vectors (2013) 0.93
Genetic vaccines protect against Sin Nombre hantavirus challenge in the deer mouse (Peromyscus maniculatus). J Gen Virol (2002) 0.92
Zoonotic infections in native communities of James Bay, Canada. Vector Borne Zoonotic Dis (2012) 0.92
Neutralizing antibodies in survivors of Sin Nombre and Andes hantavirus infection. Emerg Infect Dis (2006) 0.91
A preliminary study of the patterns of Sin Nombre viral infection and shedding in naturally infected deer mice (Peromyscus maniculatus). Vector Borne Zoonotic Dis (2005) 0.91
Seroprevalence of West Nile virus in Saskatchewan's Five Hills Health Region, 2003. Can J Public Health (2006) 0.90
Detecting West Nile virus in owls and raptors by an antigen-capture assay. Emerg Infect Dis (2004) 0.89
Development and evaluation of serological assays for detection of human hantavirus infections caused by Sin Nombre virus. J Clin Virol (2005) 0.89
Seroprevalence of 10 zoonotic infections in 2 Canadian Cree communities. Diagn Microbiol Infect Dis (2011) 0.89
Elevated generation of reactive oxygen/nitrogen species in hantavirus cardiopulmonary syndrome. J Virol (2002) 0.88
Hantavirus fever without pulmonary syndrome in Panama. Am J Trop Med Hyg (2013) 0.88
Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade. Antimicrob Agents Chemother (2008) 0.88
Ross River virus disease reemergence, Fiji, 2003-2004. Emerg Infect Dis (2005) 0.87
Recognition of decay accelerating factor and alpha(v)beta(3) by inactivated hantaviruses: Toward the development of high-throughput screening flow cytometry assays. Anal Biochem (2010) 0.87
[The new-world hantaviruses. Ecology and epidemiology of an emerging virus in Latin America]. Medicina (B Aires) (2006) 0.87
Rapid and simple method for screening wild rodents for antibodies to Sin Nombre hantavirus. J Wildl Dis (2003) 0.87
Roles of host species, geographic separation, and isolation in the seroprevalence of Jamestown Canyon and snowshoe hare viruses in Newfoundland. Appl Environ Microbiol (2012) 0.86
Development and evaluation of one-step rRT-PCR and immunohistochemical methods for detection of Rift Valley fever virus in biosafety level 2 diagnostic laboratories. J Virol Methods (2011) 0.85
Prognosis of West Nile virus associated acute flaccid paralysis: a case series. J Med Case Rep (2011) 0.84
A non-randomized multicentre trial of human immune plasma for treatment of hantavirus cardiopulmonary syndrome caused by Andes virus. Antivir Ther (2014) 0.84
Spatial but not temporal co-divergence of a virus and its mammalian host. Mol Ecol (2011) 0.84
Profiling helper T cell subset gene expression in deer mice. BMC Immunol (2006) 0.83
Characterization of monoclonal antibodies against hantavirus nucleocapsid protein and their use for immunohistochemistry on rodent and human samples. Arch Virol (2010) 0.82
Blood collected on filter paper for wildlife serology: detecting antibodies to Neospora caninum, West Nile virus, and five bovine viruses in reindeer. J Wildl Dis (2014) 0.82
Selection and characterization of scFv antibodies against the Sin Nombre hantavirus nucleocapsid protein. J Immunol Methods (2007) 0.82
Incidence rate for hantavirus infections without pulmonary syndrome, Panama. Emerg Infect Dis (2011) 0.81
Sin Nombre virus shedding patterns in naturally infected deer mice (Peromyscus maniculatus) in relation to duration of infection. Vector Borne Zoonotic Dis (2008) 0.81
Case report: T-cell responses during clearance of Andes virus from blood cells 2 months after severe hantavirus cardiopulmonary syndrome. J Med Virol (2008) 0.81
Phage display selection of cyclic peptides that inhibit Andes virus infection. J Virol (2009) 0.81
Young man with kidney failure and hemorrhagic interstitial nephritis. Am J Kidney Dis (2009) 0.81
Recommendations for publication of viral genetic data and sample access for novel viruses and strains. Am J Trop Med Hyg (2012) 0.81
A case of Japanese encephalitis virus infection acquired during a trip in Thailand. J Travel Med (2012) 0.80
Pathology and tissue distribution of West Nile virus in North American owls (family: Strigidae). Avian Pathol (2006) 0.80
Evaluating the use of house sparrow nestlings as sentinels for West Nile virus in Saskatchewan. Vector Borne Zoonotic Dis (2010) 0.80
Andes virus infections in the rodent reservoir and in humans vary across contrasting landscapes in Chile. Infect Genet Evol (2009) 0.79
Effects of heavy metals on immunocompetence of white-footed mice (Peromyscus leucopus). J Wildl Dis (2004) 0.79
Blood collected on filter paper for wildlife serology: evaluating storage and temperature challenges of field collections. J Wildl Dis (2014) 0.79
Epidemiology of Lyme Disease, Nova Scotia, Canada, 2002-2013. Emerg Infect Dis (2015) 0.79
Sin Nombre virus infection in field workers, Colorado, USA. Emerg Infect Dis (2010) 0.79
West Nile virus encephalitis in a Barbary macaque (Macaca sylvanus). Emerg Infect Dis (2004) 0.79